A detailed history of West Family Investments, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, West Family Investments, Inc. holds 5,719 shares of BMY stock, worth $319,291. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,719
Holding current value
$319,291
% of portfolio
0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $226,815 - $295,958
5,719 New
5,719 $295,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $76,048 - $86,224
-1,585 Reduced 26.0%
4,511 $244,000
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $115,430 - $137,740
2,381 Added 64.09%
6,096 $312,000
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $489,575 - $547,421
-8,457 Reduced 69.48%
3,715 $215,000
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $775,478 - $861,047
12,172 New
12,172 $778,000
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $121,483 - $143,853
1,774 Added 16.93%
12,254 $881,000
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $77 - $45,950
598 Added 6.05%
10,480 $745,000
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $292,513 - $322,159
4,028 Added 68.81%
9,882 $761,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $62,279 - $74,678
1,013 Added 20.93%
5,854 $427,000
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $145,873 - $170,054
-2,720 Reduced 35.97%
4,841 $302,000
Q3 2021

Oct 25, 2021

BUY
$59.17 - $69.31 $25,857 - $30,288
437 Added 6.13%
7,561 $447,000
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $441,046 - $480,300
7,124 New
7,124 $476,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track West Family Investments, Inc. Portfolio

Follow West Family Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.